Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Individual timelines vary based on genetics, diet quality, and activity level
Exploratory endpoints included achieving 15% and 20% weight loss, and patient-reported outcomes assessed using the SF-36 v2.0 and the Three-Factor Eating Questionnaire (TFEQ-R18 v2)
In this first scenario, we ballpark the adoption in the US to be around 20% of the adult population in the next five years
Off-label use of approved medications is legal and common in obesity medicine
Available at: (Accessed 30 April 2023)
US$ 27.10
,aspect=ignore)
US$ 22.50
US$ 26.15
US$ 25.90
US$ 25.89
US$ 23.53
US$ 24.65
